PRIMARY PERITONEAL CLEAR CELL ADENOCARCINOMA
Clinical trials for PRIMARY PERITONEAL CLEAR CELL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PRIMARY PERITONEAL CLEAR CELL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for PRIMARY PERITONEAL CLEAR CELL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to drain ovarian Cancer's fluid trap
Disease control Recruiting nowThis study tests whether adding an experimental drug (APL-2) to standard immunotherapy (pembrolizumab) and a targeted therapy (bevacizumab) works better than bevacizumab alone for recurrent ovarian, fallopian tube, or peritoneal cancer that causes fluid buildup. About 60 adults w…
Matched conditions: PRIMARY PERITONEAL CLEAR CELL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 26, 2026 03:40 UTC
-
Less invasive surgery may help ovarian cancer patients recover faster
Disease control Recruiting nowThis study tests if a less invasive surgery (laparoscopy) works as well as standard open surgery for people with advanced ovarian, fallopian tube, or peritoneal cancer who have already had chemotherapy. About 580 participants will be randomly assigned to one of the two surgeries.…
Matched conditions: PRIMARY PERITONEAL CLEAR CELL ADENOCARCINOMA
Phase: PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 03:28 UTC
-
New vaccine aims to keep ovarian cancer at bay
Disease control Recruiting nowThis study tests a vaccine made from a patient's own white blood cells, designed to train the immune system to attack ovarian cancer cells. It is for people with advanced stage III or IV ovarian, fallopian tube, or primary peritoneal cancer. The goal is to see if the vaccine can …
Matched conditions: PRIMARY PERITONEAL CLEAR CELL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 11, 2026 20:41 UTC